Aviva PLC Eli Lilly & CO Transaction History

Aviva PLC

$36.8 Billion
Q3 2024

A detailed history of Aviva PLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Aviva PLC holds 513,032 shares of LLY stock, worth $387 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares

513,032

Previous 499,077 2.8%

Holding current value

$387 Million

Previous $452 Million 0.59%

% of portfolio

1.23%

Previous 1.32%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $10.8 Million - $13.4 Million	13,955 Added 2.8%	513,032 $455 Million
Q2 2024 Aug 02, 2024	BUY	$724.87 - $909.04 $66.4 Million - $83.2 Million	91,541 Added 22.46%	499,077 $452 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $8.18 Million - $10.9 Million	13,812 Added 3.51%	407,536 $317 Million
Q4 2023 Feb 09, 2024	BUY	$525.19 - $619.13 $7.73 Million - $9.11 Million	14,720 Added 3.88%	393,724 $230 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $2.57 Million - $3.55 Million	-5,921 Reduced 1.54%	379,004 $204 Million
Q2 2023 Aug 10, 2023	BUY	$350.74 - $468.98 $52.9 Million - $70.8 Million	150,873 Added 64.46%	384,925 $181 Million
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $18.1 Million - $21.2 Million	-58,247 Reduced 19.93%	234,052 $80.4 Million
Q4 2022 Feb 09, 2023	BUY	$321.55 - $374.67 $15.6 Million - $18.2 Million	48,649 Added 19.97%	292,299 $107 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $1.04 Million - $1.19 Million	3,513 Added 1.46%	243,650 $78.8 Million
Q2 2022 Aug 04, 2022	BUY	$278.73 - $327.27 $2.67 Million - $3.14 Million	9,590 Added 4.16%	240,137 $77.9 Million
Q1 2022 May 13, 2022	SELL	$234.69 - $291.66 $11 Million - $13.7 Million	-47,063 Reduced 16.95%	230,547 $66 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $306,020 - $379,773	-1,361 Reduced 0.49%	277,610 $76.7 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $2.49 Million - $3.07 Million	-11,252 Reduced 3.88%	278,971 $64.5 Million
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $1.38 Million - $1.78 Million	-7,626 Reduced 2.56%	290,223 $66.6 Million
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $2.41 Million - $3.11 Million	14,640 Added 5.17%	297,849 $55.6 Million
Q4 2020 Feb 10, 2021	SELL	$130.46 - $172.63 $1.74 Million - $2.3 Million	-13,317 Reduced 4.49%	283,209 $47.8 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $1.69 Million - $1.96 Million	-11,583 Reduced 3.76%	296,526 $43.9 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $1.14 Million - $1.37 Million	-8,345 Reduced 2.64%	308,109 $50.6 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $403,817 - $499,811	3,392 Added 1.08%	316,454 $43.9 Million
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $1.48 Million - $1.83 Million	-13,813 Reduced 4.23%	313,062 $41.1 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $752,335 - $818,347	7,045 Added 2.2%	326,875 $36.6 Million
Q2 2019 Jul 30, 2019	SELL	$110.79 - $129.32 $1.58 Million - $1.84 Million	-14,241 Reduced 4.26%	319,830 $35.4 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $2.47 Million - $2.91 Million	-22,233 Reduced 6.24%	334,071 $43.3 Million
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $11.2 Million - $12.6 Million	-106,030 Reduced 22.93%	356,304 $41.2 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $2.33 Million - $2.91 Million	-27,092 Reduced 5.54%	462,334 $49.6 Million
Q2 2018 Aug 01, 2018	SELL	$75.7 - $86.88 $590,232 - $677,403	-7,797 Reduced 1.57%	489,426 $41.8 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $3.45 Million - $4.07 Million	-46,460 Reduced 8.55%	497,223 $38.5 Million
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $6.37 Million - $6.83 Million	-77,727 Reduced 12.51%	543,683 $45.9 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $403,076 - $447,374	5,230 Added 0.85%	621,410 $53.1 Million
Q2 2017 Aug 07, 2017	BUY	N/A	616,180	616,180 $50.7 Million

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account